haloperidol has been researched along with Hypothermia, Accidental in 39 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with chronic schizophrenia, who had been treated for a long time with chlorpromazine, haloperidol, levodopa, benserazide hydrochloride, diazepam and biperiden, developed extreme hypothermia (about 32 degrees C) when the dose of haloperidol was increased because of a deterioration of the patient's mental symptoms." | 7.69 | A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report. ( Harada, H; Igarashi, M; Nakajima, T; Okamoto, K; Sugae, S; Tsuji, M, 1994) |
| "The reversal of hypothermia, induced by reserpine or by a high (16 mg) dose of apomorphine, in male Swiss mice, does not seem to utilize a common mechanism." | 7.68 | Desipramine and nortriptyline antagonize apomorphine and reserpine hypothermia by a different mechanism. ( Borsini, F; Lecci, A; Meli, A; Volterra, G, 1990) |
| "The effects of various doses of estrogen on apomorphine (Apo)-induced hypothermia and stereotypy were investigated in ovariectomized rats." | 7.66 | The effects of estrogen on apomorphine-induced hypothermia and stereotypy in the rat. ( Fibiger, HC; Pittman, KJ, 1983) |
| "Pretreatment with haloperidol (4 mg/kg, i." | 5.35 | Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581. ( Barreiro, EJ; Betti, AH; Conrado, DJ; Fraga, CA; Kliemann, M; Neves, G; Rates, SM; Tasso, L, 2008) |
| "Haloperidol alone did not lower body temperature, but it potentiated the body temperature lowering effect of NT77L." | 5.31 | Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. ( Boules, M; Fauq, A; Jackson, J; McCormick, D; McMahon, B; Richelson, E; Stewart, J; Warrington, L, 2001) |
| " There is a strong genetic and pharmacological evidence supporting the hypothesis that activation of D2 receptors could lead to hypothermia and that the treatment haloperidol is capable of inducing hypothermia apomorfino similarily in laboratory animals." | 3.79 | What about temperature? Haloperidol-induced hypotermia. ( Aguglia, E; Battiato, M; Nalis, F; Signorelli, MS, 2013) |
| " We examined the effects of six compounds (memantine, dextromethorphan, haloperidol, lamotrigine, oxcarbazepine, and topiramate) on sensitivity to acute intoxicating effects of ethanol (ataxia, hypothermia, sedation/hypnosis) in C57BL/6J mice." | 3.75 | Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress. ( Chen, YC; Holmes, A, 2009) |
| "In order to better define the role of 5-HT(1A) receptors in the modulation of extrapyramidal motor functions, we investigated the effect of 5-HT(1A) agonists on tacrine-induced tremulous jaw movements (TJM) in rats, a putative model of parkinsonian tremor." | 3.73 | In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. ( Artaiz, I; Castro, E; Del Olmo, E; Innerárity, A; Labeaga, L; Orjales, A; Pazos, A; Zazpe, A, 2006) |
| "We have examined the effects of the psychostimulant d-amphetamine and the neuroleptic haloperidol on hypothermia induced by intraperitoneal injection of the centrally penetrating opioids morphine, fentanyl and sufentanil and the peripherally acting opioid loperamide." | 3.72 | Morphine and d-amphetamine nullify each others' hypothermic effects in mice. ( Baker, A; Meert, T, 2003) |
| "A patient with chronic schizophrenia, who had been treated for a long time with chlorpromazine, haloperidol, levodopa, benserazide hydrochloride, diazepam and biperiden, developed extreme hypothermia (about 32 degrees C) when the dose of haloperidol was increased because of a deterioration of the patient's mental symptoms." | 3.69 | A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report. ( Harada, H; Igarashi, M; Nakajima, T; Okamoto, K; Sugae, S; Tsuji, M, 1994) |
| " Both ASP and GLU produced a hyperthermic response in all animals, including those in which hypothermia was induced by reserpine." | 3.69 | Effect of aspartate and glutamate on nociception, catalepsy and core temperature in rats. ( Gupta, MC; Singh, J, 1997) |
| "Remoxipride and its active metabolites, the phenolic compounds FLA797(-) and FLA908(-) and the catecholic NCQ436(-) and haloperidol, were examined for their ability to block hypothermia in the rat induced by dopamine (DA) D2 receptor stimulation." | 3.68 | Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat. ( Lundström, J; Nilsson, LB; Ogren, SO; Widman, M, 1993) |
| "The reversal of hypothermia, induced by reserpine or by a high (16 mg) dose of apomorphine, in male Swiss mice, does not seem to utilize a common mechanism." | 3.68 | Desipramine and nortriptyline antagonize apomorphine and reserpine hypothermia by a different mechanism. ( Borsini, F; Lecci, A; Meli, A; Volterra, G, 1990) |
| "The hypothermia induced by apomorphine, a mixed dopamine (DA) agonist in male Swiss-Webster mice, was not blocked by the selective D-1 antagonist SCH 23390 but was completely blocked by the selective D-2 antagonists haloperidol, sulpiride and YM-09151-2." | 3.67 | Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice. ( Fitten, J; Gordon, LI; Kodama, CK; Menon, MK, 1988) |
| "A new benzamide, cis-N-(1-benzyl-2-methylpyrrolidin - 3 - yl) - 5 - chloro - 2 - methoxy - 4 - methylaminobenzamide (YM-09151-2) exhibited more potent and longer-lasting inhibitory effects on apomorphine-induced behaviours (stereotyped behaviour, emesis and hypothermia), and methamphetamine-induced stereotyped behaviour, conditioned avoidance response and open field behaviour, conditioned avoidance response and open field behaviour than either structurally similar benzamides (YM-0850 and sulpiride) or classical neuroleptics [chlorpromazine (CPZ) and haloperidol(HPD)]." | 3.66 | Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity. ( Maeno, H; Nishikori, K; Noshiro, O; Usuda, S, 1981) |
| "The effects of various doses of estrogen on apomorphine (Apo)-induced hypothermia and stereotypy were investigated in ovariectomized rats." | 3.66 | The effects of estrogen on apomorphine-induced hypothermia and stereotypy in the rat. ( Fibiger, HC; Pittman, KJ, 1983) |
| "Intraperitoneal administration of either haloperidol or chlorpromazine produced hypothermia both in the cold (8 degrees C) and at room temperature (22 degrees C)." | 3.66 | Haloperidol produces hypothermic effects in rats. ( Chern, YF; Lin, MT; Wang, HS; Wang, Z, 1979) |
| "The effects of psychotropic drugs on brain inflammation may contribute to their therapeutic mechanism but also to their toxicological profile." | 1.43 | Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats. ( Azab, AN; Nassar, A; Sharon-Granit, Y, 2016) |
| "Pretreatment with haloperidol (4 mg/kg, i." | 1.35 | Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581. ( Barreiro, EJ; Betti, AH; Conrado, DJ; Fraga, CA; Kliemann, M; Neves, G; Rates, SM; Tasso, L, 2008) |
| " Thus, for example, NT69L after five daily injections at a fixed dosage was as effective at reversing cocaine-induced hyperactivity as after the first injection." | 1.32 | Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier. ( Boules, M; Fauq, A; McCormick, D; McMahon, B; Richelson, E; Stewart, J; Wang, R; Warrington, L; Yerbury, S, 2003) |
| "KCH-1110 did not induce catalepsy in mice, but at much higher doses only a slight catalepsy response was shown." | 1.32 | Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110. ( Cho, H; Cho, YS; Choi, KI; Jeong, D; Jung, JY; Jung, SH; Kim, GD; Koh, HY; Kong, JY; Lee, S; Pae, AN; Park, WK; Yun, CW, 2003) |
| "Haloperidol alone did not lower body temperature, but it potentiated the body temperature lowering effect of NT77L." | 1.31 | Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. ( Boules, M; Fauq, A; Jackson, J; McCormick, D; McMahon, B; Richelson, E; Stewart, J; Warrington, L, 2001) |
| " This variation for fluphenazine may be explained by the fact that its pKa value is closer to that of piracetam, thus preventing better bioavailability of the neuroleptic, or its better affinity for DA-1 dopaminergic receptors." | 1.27 | Piracetam interactions with neuroleptics in psychopharmacological tests. ( Bourin, M; Larousse, C; Poisson, L, 1986) |
| " Intraventricular injection of phenylephrine produced a dose-dependent hypothermia, whereas no dose-response relationship was obtained by isoproterenol." | 1.25 | [Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)]. ( Fukushima, N, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (41.03) | 18.7374 |
| 1990's | 7 (17.95) | 18.2507 |
| 2000's | 12 (30.77) | 29.6817 |
| 2010's | 3 (7.69) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Arditti, R | 1 |
| Mongin, Y | 1 |
| Drancourt, N | 1 |
| Hotier, S | 1 |
| Laguerre, A | 1 |
| Hamdani, N | 1 |
| Elbakary, NAH | 1 |
| Ouanes, S | 1 |
| Signorelli, MS | 1 |
| Nalis, F | 1 |
| Battiato, M | 1 |
| Aguglia, E | 1 |
| Nassar, A | 1 |
| Sharon-Granit, Y | 1 |
| Azab, AN | 1 |
| Chen, YC | 1 |
| Holmes, A | 1 |
| Chintawar, SD | 1 |
| Somani, RS | 1 |
| Kasture, VS | 1 |
| Kasture, SB | 1 |
| Baker, A | 1 |
| Meert, T | 1 |
| GAYRAL, L | 1 |
| ROUX, G | 1 |
| TURNIN, J | 1 |
| Boules, M | 2 |
| McMahon, B | 2 |
| Wang, R | 1 |
| Warrington, L | 2 |
| Stewart, J | 2 |
| Yerbury, S | 1 |
| Fauq, A | 2 |
| McCormick, D | 2 |
| Richelson, E | 2 |
| Park, WK | 1 |
| Jeong, D | 1 |
| Yun, CW | 1 |
| Lee, S | 1 |
| Cho, H | 1 |
| Kim, GD | 1 |
| Koh, HY | 1 |
| Pae, AN | 1 |
| Cho, YS | 1 |
| Choi, KI | 1 |
| Jung, JY | 1 |
| Jung, SH | 1 |
| Kong, JY | 1 |
| Zazpe, A | 1 |
| Artaiz, I | 1 |
| Innerárity, A | 1 |
| Del Olmo, E | 1 |
| Castro, E | 1 |
| Labeaga, L | 1 |
| Pazos, A | 1 |
| Orjales, A | 1 |
| Neves, G | 1 |
| Kliemann, M | 1 |
| Betti, AH | 1 |
| Conrado, DJ | 1 |
| Tasso, L | 1 |
| Fraga, CA | 1 |
| Barreiro, EJ | 1 |
| Rates, SM | 1 |
| Nemeroff, CB | 1 |
| Aimoto, T | 1 |
| Kaida, M | 1 |
| Sato, M | 2 |
| Kimura, R | 1 |
| Murata, T | 1 |
| Monteiro Filho, RC | 1 |
| Bojikian, BU | 1 |
| Matsubara, LS | 1 |
| Trezza, E | 1 |
| Usuda, S | 1 |
| Nishikori, K | 1 |
| Noshiro, O | 1 |
| Maeno, H | 1 |
| Cools, AR | 1 |
| van Rossum, JM | 1 |
| Pittman, KJ | 1 |
| Fibiger, HC | 1 |
| Lai, H | 1 |
| Kazi, MS | 1 |
| Carino, MA | 1 |
| Horita, A | 1 |
| Ali, SF | 1 |
| Newport, RR | 1 |
| Holson, W | 1 |
| Slikker, W | 1 |
| Bowyer, JF | 1 |
| Harada, H | 1 |
| Igarashi, M | 1 |
| Sugae, S | 1 |
| Okamoto, K | 1 |
| Tsuji, M | 1 |
| Nakajima, T | 1 |
| Patel, A | 1 |
| Getsos, JP | 1 |
| Moussa, G | 1 |
| Damato, AN | 1 |
| Ogren, SO | 1 |
| Lundström, J | 1 |
| Nilsson, LB | 1 |
| Widman, M | 1 |
| Singh, J | 1 |
| Gupta, MC | 1 |
| Cryan, JF | 1 |
| Harkin, A | 1 |
| Naughton, M | 1 |
| Kelly, JP | 1 |
| Leonard, BE | 1 |
| Mohan, MS | 1 |
| Patole, SK | 1 |
| Whitehall, JS | 1 |
| Hägg, S | 1 |
| Mjörndal, T | 1 |
| Lindqvist, L | 1 |
| Jackson, J | 1 |
| Catalina, F | 1 |
| Milewich, L | 1 |
| Frawley, W | 1 |
| Kumar, V | 1 |
| Bennett, M | 1 |
| Lin, MT | 1 |
| Wang, HS | 1 |
| Wang, Z | 1 |
| Chern, YF | 1 |
| Drawbaugh, RB | 1 |
| Lal, H | 1 |
| Fukushima, N | 1 |
| Volterra, G | 1 |
| Borsini, F | 1 |
| Lecci, A | 1 |
| Meli, A | 1 |
| MacDonell, JE | 1 |
| Wrenn, K | 1 |
| Bourin, M | 1 |
| Poisson, L | 1 |
| Larousse, C | 1 |
| Menon, MK | 1 |
| Gordon, LI | 1 |
| Kodama, CK | 1 |
| Fitten, J | 1 |
| Chipkin, RE | 1 |
| Heh, CW | 1 |
| Herrera, J | 1 |
| DeMet, E | 1 |
| Potkin, S | 1 |
| Costa, J | 1 |
| Sramek, J | 1 |
| Hazlett, E | 1 |
| Buchsbaum, MS | 1 |
| Yehuda, S | 1 |
| Wurtman, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Thermoregulation Among Individuals With First-episode Psychosis[NCT04369677] | 20 participants (Anticipated) | Observational | 2023-11-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for haloperidol and Hypothermia, Accidental
| Article | Year |
|---|---|
Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Behavior, Animal; Brain; Cats; Corpus Striatum; Dextroamphe | 1980 |
1 trial available for haloperidol and Hypothermia, Accidental
| Article | Year |
|---|---|
Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia.
Topics: Adult; Analysis of Variance; Body Temperature; Clozapine; Dibenzazepines; Haloperidol; Humans; Hypot | 1988 |
37 other studies available for haloperidol and Hypothermia, Accidental
| Article | Year |
|---|---|
[Hypothermia due to antipsychotic drug: A case report].
Topics: Adult; Antipsychotic Agents; Consciousness Disorders; Drug Substitution; Female; Haloperidol; Humans | 2020 |
First generation antipsychotic-induced severe hypothermia: A case report and review of the literature.
Topics: Antipsychotic Agents; Chlorpromazine; Diagnosis, Differential; Drug Administration Schedule; Female; | 2019 |
What about temperature? Haloperidol-induced hypotermia.
Topics: Antipsychotic Agents; Body Temperature; Female; Follow-Up Studies; Haloperidol; Humans; Hypothermia; | 2013 |
Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats.
Topics: Animals; Carbamazepine; Dinoprostone; Encephalitis; Haloperidol; Hypothalamus; Hypothermia; Imiprami | 2016 |
Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress.
Topics: Alcoholic Intoxication; Animals; Ataxia; Carbamazepine; Central Nervous System Depressants; Consciou | 2009 |
Nootropic activity of Albizzia lebbeck in mice.
Topics: Albizzia; Animals; Avoidance Learning; Behavior, Animal; Brain Chemistry; Catalepsy; Clonidine; Depr | 2002 |
Morphine and d-amphetamine nullify each others' hypothermic effects in mice.
Topics: Analgesics, Opioid; Animals; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Do | 2003 |
[LATENT NEURO-VEGETATIVE DISORDERS DURING CURES WITH NEUROLEPTICS. INCIDENTS AND ACCIDENTS IN CHILDREN AND ADOLESCENTS].
Topics: Accidents; Antipsychotic Agents; Child; Chlorpromazine; Cyanosis; Fluphenazine; Haloperidol; Humans; | 1964 |
Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Topics: Amphetamine; Animals; Behavior, Animal; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain; | 2003 |
Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.
Topics: Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Body Temperature; Catalepsy; Cell L | 2003 |
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Avoidance Lea | 2006 |
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Haloperidol; Hypothermia; Injecti | 2008 |
Neurotensin: perchance an endogenous neuroleptic?
Topics: Analgesics; Animals; Antipsychotic Agents; Drug Synergism; Haloperidol; Humans; Hypothermia; Mice; M | 1980 |
Effects of neuroleptic butyrophenones on pituitary-adrenal activity in rats.
Topics: Adrenal Glands; Animals; Antipsychotic Agents; Corticosterone; Female; Haloperidol; Hypothermia; Kin | 1980 |
[Hypothermia - clinical, laboratory and electrocardiographic changes. Report of a case].
Topics: Adult; Antipsychotic Agents; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Halo | 1980 |
Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Chlorpropamide; Dogs; Drug Evaluation, Precl | 1981 |
The effects of estrogen on apomorphine-induced hypothermia and stereotypy in the rat.
Topics: Animals; Apomorphine; Cold Temperature; Dopamine; Estradiol; Haloperidol; Humans; Hypothalamus, Ante | 1983 |
Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
Topics: Animals; Apomorphine; Binding Sites; Corpus Striatum; Drug Synergism; Ethanol; Haloperidol; Humans; | 1982 |
Low environmental temperatures or pharmacologic agents that produce hyperthermia decrease methamphetamine neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cold Temperature; Corpus Striatum; Dizocilpine Maleate; Dop | 1995 |
A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Huma | 1994 |
The Osborn wave of hypothermia in normothermic patients.
Topics: Adult; Aged; Angina Pectoris; Body Temperature; Chest Pain; Cocaine; Electrocardiography; Female; Ha | 1994 |
Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
Topics: Animals; Body Temperature; Chromatography, High Pressure Liquid; Dopamine D2 Receptor Antagonists; E | 1993 |
Effect of aspartate and glutamate on nociception, catalepsy and core temperature in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesia; Analgesics, Opioid; Animals; Aspartic Acid; Body Temperatur | 1997 |
Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Benzofurans; Body Temperature; Cerebral | 2000 |
Severe hypothermia in a neonate following antenatal exposure to haloperidol.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Hypothermia; Infant, Newborn; Male; Pregna | 2000 |
Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Hypothermia; Methotrimepra | 2001 |
Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties.
Topics: Analgesics; Animals; Antipsychotic Agents; Blood-Brain Barrier; Body Temperature; Catalepsy; Corpus | 2001 |
Decrease of core body temperature in mice by dehydroepiandrosterone.
Topics: 5,7-Dihydroxytryptamine; Androsterone; Animals; Body Temperature; Dehydroepiandrosterone; Diet; Dopa | 2002 |
Haloperidol produces hypothermic effects in rats.
Topics: Animals; Body Temperature; Body Temperature Regulation; Chlorpromazine; Haloperidol; Hypothermia; Ma | 1979 |
Effect of pharmacological interference with various neuropathways on blockade of morphine-withdrawal hypothermia by morphine and by conditional stimulus.
Topics: Animals; Benztropine; Conditioning, Classical; Cyproheptadine; Haloperidol; Humans; Hypothermia; Mal | 1976 |
[Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
Topics: Adaptation, Physiological; Animals; Biogenic Amines; Blood Glucose; Body Temperature Regulation; Cer | 1975 |
Desipramine and nortriptyline antagonize apomorphine and reserpine hypothermia by a different mechanism.
Topics: Animals; Apomorphine; Body Temperature; Desipramine; Haloperidol; Hypothermia; Injections, Intraperi | 1990 |
Hypothermia in the summer.
Topics: Adult; Aged; Alcoholism; Emergencies; Haloperidol; Humans; Hypothermia; Male; Mental Disorders; Nutr | 1991 |
Piracetam interactions with neuroleptics in psychopharmacological tests.
Topics: Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Drug Interactions; Fluph | 1986 |
Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Apomorphin | 1988 |
Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
Topics: Animals; Apomorphine; Benzazepines; Body Temperature; Dopamine Antagonists; Haloperidol; Hypothermia | 1988 |
Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
Topics: Animals; Apomorphine; Brain Chemistry; Clonidine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamin | 1972 |